GSK plc (LON:GSK) Receives Consensus Rating of “Moderate Buy” from Analysts

GSK plc (LON:GSK) has received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is GBX 1,805.71 ($23.85).

A number of analysts recently weighed in on the stock. Shore Capital reiterated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 2,100 ($27.74) target price on shares of GSK in a research note on Thursday, June 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,850 ($24.44) price target on shares of GSK in a research report on Tuesday, September 3rd. Citigroup decreased their price objective on GSK from GBX 2,120 ($28.01) to GBX 1,900 ($25.10) and set a “buy” rating for the company in a research report on Friday, July 5th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 1,820 ($24.04) price target on shares of GSK in a research note on Tuesday, September 10th.

GSK Trading Down 0.6 %

Shares of LON GSK opened at GBX 1,600 ($21.14) on Wednesday. The company’s 50 day simple moving average is GBX 1,578.96 and its 200 day simple moving average is GBX 1,634.21. The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73. The firm has a market capitalization of £65.28 billion, a P/E ratio of 1,424.34, a P/E/G ratio of 1.34 and a beta of 0.31. GSK has a fifty-two week low of GBX 1,371.40 ($18.12) and a fifty-two week high of GBX 1,823.50 ($24.09).

GSK Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, October 10th. Investors of record on Thursday, August 15th will be given a GBX 15 ($0.20) dividend. This represents a yield of 0.97%. The ex-dividend date of this dividend is Thursday, August 15th. GSK’s dividend payout ratio (DPR) is currently 5,309.73%.

Insiders Place Their Bets

In related news, insider Wendy Becker bought 446 shares of the company’s stock in a transaction that occurred on Thursday, June 20th. The shares were acquired at an average price of GBX 1,614 ($21.32) per share, for a total transaction of £7,198.44 ($9,509.17). Insiders own 1.61% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.